The U.S. Supreme Court ruled that the abortion pill Mifepristone can continue to be available by mail without requiring an in-person appointment with a clinician.

The decision comes after a ruling by the 5th U.S. Circuit Court of Appeals in New Orleans on May 1 that threatened widespread access to the pill.

The decision marks a setback for the state of Louisiana and ensures that litigation will not disrupt access to the drug.

On May 4, the court, led by conservative Justice Samuel Alito, had provisionally paused the appeals court ruling while the justices considered their next steps, according to multiple published reports.